Assertion: psilocybin | /r/HasProperty | listed as controlled substances
Facets:
value: in switzerland
type: LOCATION
value: according to the drug enforcement administration
type: OTHER
value: by microdosing
type: MANNER
value: by extension
type: OTHER
value: largely
type: DEGREE
value: currently
type: TEMPORAL
Source sentences:
text: Although psilocybin and psilocin have long been listed as controlled substances in Switzerland, mushrooms themselves were only specifically banned in 2002, initially by the Swiss Agency for Therapeutic Products and later, by a revision of the Swiss Narcotics Act in 2008.
text: Although psilocybin and psilocin have long been listed as controlled substances in Switzerland, mushrooms themselves were only specifically banned in 2002, initially by the Swiss Agency for Therapeutic Products and later, by a revision of the Swiss Narcotics Act in 2008.
text: Psilocybin is a controlled drug and one of the ingredients of so-called ‘magic mushrooms’.
text: However, psilocybin and psilocin are Schedule I controlled substances, according to the Drug Enforcement Administration.
text: Psilocybin is currently a Schedule I controlled substance.
text: However, psilocybin and psilocin are Schedule I controlled substances, according to the Drug Enforcement Administration.
text: A: While several countries do allow the cultivation of psilocybin mushrooms, psilocybin is largely an class A or schedule 1 controlled substance and thus possession of psilocybin and, by extension, microdosing, is wholly illegal and should not be performed in regions in which it is against the law.
text: Although psilocybin and psilocin have long been listed as controlled substances in Switzerland, mushrooms themselves were only specifically banned in 2002, initially by the Swiss Agency for Therapeutic Products and later, by a revision of the Swiss Narcotics Act in 2008.
text: Although psilocybin and psilocin have long been listed as controlled substances in Switzerland, mushrooms themselves were only specifically banned in 2002, initially by the Swiss Agency for Therapeutic Products and later, by a revision of the Swiss Narcotics Act in 2008.